LENZ Stock Plunges After Retinal Tear Case Linked to VIZZ Eye Drops

LENZ Therapeutics shares dropped 27% following reports of a retinal tear associated with VIZZ presbyopia treatment, raising investor safety concerns despite company reassurances.